What Is the Cost of Medullary Carcinoma Treatment in Germany?
The cost of Medullary Carcinoma treatment in Germany typically ranges from $18,000 to $70,000 USD, depending on the hospital, city, and type of procedure.
This page covers medullary thyroid carcinoma (MTC), a rare thyroid cancer that starts in the C cells of the thyroid gland. The term medullary carcinoma is also used for a rare type of breast cancer, which is not covered here. In Germany, the total depends on:
- Surgery: total thyroidectomy with removal of neck lymph nodes.
- Genetic testing: for RET gene changes.
- Targeted drugs: for advanced or progressing cancer.
- Monitoring: calcitonin and CEA blood tests.
Cancer treatment costs depend on the stage and the treatments needed. A full course of care can cost more than this range, so ask what each estimate includes.
Medullary Thyroid Carcinoma: Genetics and Tests
A plain-language summary in Drugs in Context explains that MTC accounts for about 2 to 5% of thyroid cancers and arises from the parafollicular C cells. Calcitonin is the main blood marker, with CEA also measured.
About 25 to 30% of cases are hereditary, linked to changes in the RET gene (MEN2A or MEN2B), so genetic testing is recommended for everyone with MTC. Relatives found to carry a RET change may be offered preventive thyroid surgery.
Our Services for Medullary Carcinoma Treatment in Germany
Transparent, professional support—without the hassles.
Book Doctor Appointment
Choose a specialist and schedule a convenient consultation.
Video or In-person Consultation
Consult remotely or meet your doctor directly at the hospital.
Compare Cost Estimates
Review transparent estimates from suitable hospitals.
Hospitalisation Support
Get coordinated assistance throughout your hospital stay.
Surgery and Targeted Medicines for MTC
Total thyroidectomy with removal of neck lymph nodes is the standard treatment. In families with hereditary disease, a check for an adrenal tumour (phaeochromocytoma) is done before surgery.
Radioactive iodine does not work for MTC because C cells do not take up iodine. Up to half of patients have some disease remaining after surgery, and selpercatinib is preferred for RET-mutated cancers that need treatment, with vandetanib and cabozantinib as other options.
Medullary Thyroid Cancer Treatment in Germany
Because MTC can be hereditary, international patients may want genetic counselling for relatives as well as treatment. Ask whether the estimate covers genetic testing. International patients are usually treated in Germany as self-paying patients: the hospital reviews the medical reports, sends a cost estimate and asks for an advance payment before admission, then settles the final bill after discharge.
Top Hospitals in Germany
Recommended Hospitals for Medullary Carcinoma Treatment
Frequently Asked Questions Related to Medullary Carcinoma Treatment Cost in Germany
Medullary thyroid carcinoma is a rare thyroid cancer that starts in the C cells, which make the hormone calcitonin. It makes up about 2 to 5% of thyroid cancers.
About 25 to 30% of cases are hereditary, linked to changes in the RET gene. Genetic testing is recommended for everyone with MTC.
Calcitonin is made by C cells and is the main blood marker for MTC. Rising levels after surgery can show that disease remains or has returned.
Total thyroidectomy with removal of nearby neck lymph nodes is the standard treatment. It aims to remove all visible cancer.
No, radioactive iodine is not effective for MTC because C cells do not absorb iodine. This differs from other thyroid cancers.
Selpercatinib is a targeted drug that blocks the effect of RET gene changes. It is preferred for RET-mutated MTC that needs drug treatment.
The cost of Medullary Carcinoma treatment in Germany typically ranges from $18,000 to $70,000 USD, depending on the hospital, city, and type of procedure.
Relatives found to carry a RET gene change may be offered thyroid removal before cancer develops. Genetic counselling helps families decide.
Hereditary MTC can come with an adrenal tumour called phaeochromocytoma. This must be found and treated first to make thyroid surgery safe.
No, this page covers medullary thyroid carcinoma. Medullary breast carcinoma is a different, rare type of breast cancer that is treated as breast cancer.














